Drug Profile
TAK 583
Alternative Names: TAK-583Latest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Takeda
- Class Analgesics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetic neuropathies; Postherpetic neuralgia
Most Recent Events
- 04 Nov 2008 Discontinued - Phase-II for Diabetic neuropathies in Europe (PO)
- 04 Nov 2008 Discontinued - Phase-II for Diabetic neuropathies in Japan (PO)
- 04 Nov 2008 Discontinued - Phase-II for Diabetic neuropathies in USA (PO)